WHO expects deliveries of COVID vaccines to begin in the first half of 2021. This was stated by the chief researcher of the organization Sumiya Swaminathan at a briefing on Monday, November 16.
“For the first half of the year, we are planning limited supplies. We are now in the planning stage. Our goal is to ensure that people at risk have the necessary access to vaccines and are protected. This is our goal,” Swaminathan said.
This applies to healthcare workers who are at the forefront of the fight against infection, she said.
Swaminathan also drew attention to the fact that WHO at this stage is optimistic and works with all potential manufacturers. In particular, some candidate vaccines will be more suitable in some conditions, some in others. For example, some may be more suitable for older people, while others may require certain storage and transportation conditions.
“Therefore, we need a portfolio of vaccines for countries to have a choice,” concluded Swaminathan.
Pfizer previously said its COVID vaccine was over 90% effective.
At the same time, it was reported that the market entry of COVID vaccines from BioNTech and Pfizer was postponed for technical reasons.
Despite this, 600 million orders have already been placed for the Pfizer-BioNTech vaccine.